Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Diego Jose Maselli
Benralizumab, an Add-On Treatment for Severe Eosinophilic Asthma: Evaluation of Exacerbations, Emergency Department Visits, Lung Function, and Oral Corticosteroid Use
Therapeutics and Clinical Risk Management
Related publications
Benralizumab for the Treatment of Severe Eosinophilic Asthma
Prescriber
Pharmacology
Reslizumab: Add-On Therapy for Severe Eosinophilic Asthma
Prescriber
Pharmacology
Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma
Clinical Pharmacology and Therapeutics
Pharmacology
Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma
Allergy: European Journal of Allergy and Clinical Immunology
Allergy
Immunology
Factors That Influence Emergency Department Visits for Asthma
Canadian Respiratory Journal
Medicine
Pulmonary
Respiratory Medicine
Benralizumab Efficacy for Patients With Fixed Airflow Obstruction and Severe, Uncontrolled Eosinophilic Asthma
Annals of Allergy, Asthma and Immunology
Respiratory Medicine
Pulmonary
Allergy
Immunology
The Clinical Profile of Benralizumab in the Management of Severe Eosinophilic Asthma
Therapeutic Advances in Respiratory Disease
Pulmonary
Respiratory Medicine
Pharmacology
Factors Associated With Emergency Department Visits in Asthma Exacerbation
Southern Medical Journal
Medicine
Omalizumab Reduced Inhaled Corticosteroid Use and Exacerbations in Childhood Allergic Asthma
Evidence-Based Medicine
Medicine
